REFERENCES
- Hibbard JS
Analyses comparing the antimicrobial activity and safety of current antiseptic agents: A review
J Infus Nurs 2005; 28: 194-207
- Florman S, Nichols RL
Current approaches for the prevention of surgical site infections
Am J Infect Dis 2007; 3: 51-61
- Garcia R, Hibbard JS, Mulberry G et al
Comparison of Chloraprep® and Betadine® as preoperative skin preparation antiseptics
Abstracts of the Infectious Disease Society of America 40th Annual Meeting 2002: Abs 418
- Crosby CT, Mares AK
Skin antisepsis: past, present, and future
J Vasc Access Devices 2001; Spring: 26-31
- Data on file, Enturia
- Fredericks DN
Microbial Ecology of Human Skin in Health and Disease
J Invest Dermatol Symp Proc 2001; 6: 167-9
- Hendley JO, Ashe KM
Effect of topical antimicrobial treatment on aerobic bacteria in the stratum corneum of human skin
Antimicrob Agents Chemother 1991; 35: 627-31
- Milstone AM, Passaretti CL, Perl TM
Chlorhexidine: Expanding the armamentarium for infection control and prevention
CID 2008; 46: 274-80
- McDonald CP, Lowe P, Roy A
Evaluation of donor arm disinfection techniques
Vox Sanguinis 2001; 80: 135-41
- National Audit Office
The management and control of hospital acquired infection in acute NHS trusts in England
February 2000
- Plowman R, Graves N, Griffin M et al
The socioeconomic burden of hospital acquired infection
www.dh.gov.uk
- York N, Hartley-Jones c, Hutchinson J et al
The cost-effectiveness of 2% chlorhexidine gluconate in 70% isopropyl alcohol in prevention of
central venous access device-related infections in patients admitted to ITU
Poster presented at 37th Annual Infection Control Conference,
UK, September 2007
- Madeo M, Barlow G
Reducing blood-culture contamination rates by the use of a 2% chlorhexidine solution applicator
in acute admission units
Hosp Infect 2008; 69: 307-9
- Ostrander RV, Botte MJ, Brage ME
Efficacy of surgical preparation solutions in foot and ankle surgery
J Bone Joint Surg Am 2005; 87: 980-5
- Casey AL, Itrakjy AS, Harbun C et al
Prospective, randomised clinical trial to compare the efficacy of two 70% (v/v) isopropyl alcohol
(IPA) solutions containing either 0.5% (w/v) or 2% (w/v) chlorhexidine gluconate (CHG) for skin
antisepsis during coronary artery bypass grafting (CABG)
Poster presented at European Congress of Clinical Microbiology and Infection Diseases
(ECCMID), Spain, April 2008
Information
contained on this site pertains only to the United Kingdom.